查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1433542

單純皰疹病毒治療市場規模、佔有率、趨勢分析報告：按類型、藥物、疫苗、給藥途徑、最終用途、地區和細分市場預測，2024-2030 年

Herpes Simplex Virus Treatment Market Size, Share & Trends Analysis Report By Type, By Drug, By Vaccine, By Route of Administration, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格

單純皰疹病毒治療市場的成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球單純皰疹病毒治療市場規模預計將達到40.8億美元，2024年至2030年複合年成長率為8.1%。

市場開拓的推動因素包括人群中皰疹感染疾病盛行率的不斷上升、全球對該疾病的認知不斷增強、老年人和免疫力缺乏低下人群的數量不斷增加，以及滿足治療皰疹感染疾病藥物需求的新療法。因素包括需求不斷增加用於選擇權開發。此外，公共和私營部門的共同努力預計將進一步促進市場成長。

據世界衛生組織稱，2020年約有4.915億人患有由單純皰疹病毒2型引起的生殖器皰疹，還有數十億人感染了單純皰疹病毒1型。這種感染疾病通常是無症狀的，但感染者很容易透過接觸將病毒傳播給其他人。此外，全球近 80% 的人口是皰疹病毒攜帶者。這為治療皰疹感染疾病的藥物的成長創造了機會。

研究機構之間不斷增加的研究措施和合作預計將加速針對該病毒的新治療方法的開發並促進市場成長。 2020 年 1 月，洛桑聯邦理工學院、日內瓦大學 (UNIGE) 和瑞士洛桑曼徹斯特大學的科學家合作，發現了一種由糖製成的新型抗病毒物質，預計將治療單純皰疹（口唇皰疹）。開發了Buildcid 。由砂糖製成的病毒的開發促進了創新抗病毒藥物的出現，這些藥物有助於治療而不對人體有毒。

在這個市場上經營的主要公司都專注於開發新的創新產品，以滿足對提供有效治療日益成長的需求。隨著對有效治療方法的需求不斷增加，公司正致力於開發針對感染疾病的新型創新藥物。例如，2021年7月，德國製藥公司AiCuris Anti-infective Cures AG開始新藥pritelivir的III期試驗。這種代表性化合物被開發用於治療對阿昔洛韋有抗藥性的皮膚黏膜 HSV感染疾病的免疫功能免疫力缺乏患者。 2020年6月，它獲得美國FDA突破性療法認定。對創新治療方法的監管支持預計將增加進入市場的新藥數量並促進治療率的提高，從而加速市場成長。

單純皰疹病毒治療市場報告亮點

  • 從治療藥物來看，由於感染率高，HSV-1領域將在2023年佔據最大佔有率。
  • 從藥物來看，由於阿昔洛韋的功效及其作為口服和外用製劑的可用性，預計阿昔洛韋細分市場在預測期內將以最快的速度成長。
  • 在疫苗方面，simplirix 細分市場是唯一顯示出有希望結果的候選疫苗，預計在預測期內將以最快的速度成長。
  • 由於人們對性傳染病的認知不斷提高以及醫療保健支出不斷增加，北美將在 2023 年主導全球市場。

目錄

第1章 單純皰疹病毒治療市場：調查方法與範圍

第2章單純皰疹病毒治療市場：執行摘要

  • 市場概況

第3章 單純皰疹病毒治療市場：產業展望

  • 市場體系展望
  • 普及和成長前景圖
  • 市場動態
  • 波特五力分析
  • SWOT 分析，按因素（政治/法律、經濟、技術）
  • 法律規範
  • 從使用者觀點分析

第4章單純皰疹病毒治療市場：競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • Major deals &strategic alliances analysis
  • 公司/競爭對手分類
  • 供應商形勢
  • 上市公司
  • 私人公司

第5章單純皰疹病毒治療市場：類型業務分析

  • 定義和範圍
  • 2023 年及 2030 年類型市場佔有率分析
  • 2018-2030 年全球單純皰疹病毒治療市場（按類型）
  • 2018-2030年市場規模、預測及趨勢分析

第6章單純皰疹病毒治療市場：製藥業務分析

  • 定義和範圍
  • 2023 年及 2030 年藥品市場佔有率分析
  • 全球單純皰疹病毒治療市場（按藥物），2018-2030
  • 2018-2030年市場規模、預測及趨勢分析

第7章單純皰疹病毒治療市場：疫苗業務分析

  • 定義和範圍
  • 2023 年及 2030 年疫苗市場佔有率分析
  • 全球單純皰疹病毒治療市場（按疫苗），2018-2030
  • 2018-2030年市場規模、預測及趨勢分析

第8章單純皰疹病毒治療市場：給藥途徑業務分析

  • 定義和範圍
  • 2023 年及 2030 年給藥途徑市場佔有率分析
  • 全球單純皰疹病毒治療市場，依給藥途徑，2018-2030
  • 2018-2030年市場規模、預測及趨勢分析

第9章單純皰疹病毒治療市場：最終用途業務分析

  • 定義和範圍
  • 2023 年及 2030 年最終用途市場佔有率分析
  • 全球單純皰疹病毒治療市場（依最終用途），2018-2030 年
  • 2018-2030年市場規模、預測及趨勢分析

第10章單純皰疹病毒治療市場：區域業務分析

  • 定義和範圍
  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 區域市場簡介
  • 依因素（政治/法律、經濟/技術）進行 SWOT 分析
  • 2023年至2030年市場規模、預測、趨勢分析
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第11章單純皰疹病毒治療市場：公司簡介

  • 公司簡介
  • GSK plc
  • Carlsbad Tech
  • Emcure Pharmaceuticals Ltd.,
  • Sanofi
  • Glenmark Pharmaceuticals Inc.
  • Fresenius Kabi AG
  • Apotex Inc.
  • Viatris Inc. (Mylan)
  • Teva Pharmaceuticals Industries Ltd.
Product Code: GVR-4-68039-983-7

Herpes Simplex Virus Treatment Market Growth & Trends:

The global herpes simplex virus treatment market size is expected to reach USD 4.08 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 8.1% from 2024 to 2030. The growth of the market is attributed to factors such as increasing prevalence of herpes infection among the population, growing awareness about the disease globally, rising geriatric and immunocompromised population, and an increasing demand to develop novel treatment options to meet the demand for herpes infection therapeutics. Moreover, public-private initiatives are further expected to fuel the growth of the market.

According to the WHO, in 2020, nearly 491.5 million people were suffering from genital herpes caused by the herpes simplex virus 2, and several billion people have herpes simplex virus 1 infection. Although the infection is typically asymptomatic, those who have it are capable of easily transmitting the virus to another person through contact. Furthermore, nearly 80 percent of the global population is a carrier of herpes. This is creating an opportunity for the growth of herpes infection treatment drugs.

Research initiatives and increasing collaborations between research organizations are facilitating the development of novel treatment alternatives against viruses, which is anticipated to boost market growth. In January 2020, a research collaboration between scientists from the EPFL in Lausanne, Switzerland, the University of Geneva (UNIGE), and the University of Manchester led to the development of novel antiviral materials, virucides, made from sugar that show promise for the treatment of herpes simplex (cold sore virus). The development of virucides from sugar has facilitated the arrival of an innovative antiviral drug, which aids treatment without being toxic to humans.

Key players operating in the market are focusing on developing novel and innovative products to meet the increasing demand for providing effective therapeutics. With the increasing demand for effective therapeutics, companies are engaged in developing novel and innovative medicines against infection. For instance, in July 2021, a Phase III study of pritelivir, a novel drug by AiCuris Anti-infective Cures AG, which is a German pharmaceutical company, was commenced, post receiving encouraging Phase II interim results from the Phase II/III trial. This leading compound is developed to treat immunocompromised patients with mucocutaneous HSV infections that are acyclovir-resistant. It was granted Breakthrough Therapy Designation by the U.S. FDA in June 2020. The regulatory support for innovative therapies is projected to improve the number of new drugs entering the market, facilitating enhanced treatment rates, and thereby accelerating market growth.

Herpes Simplex Virus Treatment Market Report Highlights:

  • By treatment, the HSV-1 segment held the largest share in 2023 owing to the high prevalence of infection
  • By drug, the acyclovir segment is expected to grow at the fastest rate during the forecast period due to the effectiveness and availability of acyclovir as an oral and topical formulation
  • By vaccine, the simplirix segment is expected to grow at the fastest rate during the forecast period as it is the only vaccine available showing promising results as a vaccine candidate
  • North America dominated the global market in 2023 owing to the increasing awareness regarding STDs and the rise in healthcare expenditure

Table of Contents

Chapter 1 Herpes Simplex Virus Treatment Market: Methodology and Scope

  • 1.1 Research Methodology
  • 1.2 Research Assumptions
    • 1.2.1 Estimates and Forecasts timeline
  • 1.3 Information Procurement
    • 1.3.1 Purchased database
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary research
    • 1.3.5 Details of primary research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity flow analysis
      • 1.6.1.1 Approach 1: Commodity flow approach
    • 1.6.2 Volume price analysis (model 2)
      • 1.6.2.1 Approach 2: Volume price analysis
      • 1.6.2.2 Revenue modeling
  • 1.7 List of Secondary Sources
  • 1.8 List of Primary Sources

Chapter 2 Herpes Simplex Virus Treatment Market: Executive Summary

  • 2.1 Market Summary

Chapter 3 Herpes Simplex Virus Treatment Market: Industry Outlook

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market Driver Analysis
      • 3.3.1.1 Growing prevalence of herpes infection
      • 3.3.1.2 Development of novel treatment options
      • 3.3.1.3 Increasing government funding
      • 3.3.1.3 Technological advancements
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 Unavailability of vaccine
  • 3.4 Porter's Five Forces Analysis
  • 3.5 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
  • 3.6 Regulatory Framework
  • 3.7 User Perspective Analysis

Chapter 4 Herpes Simplex Virus Treatment Market: Competitive Landscape

  • 4.1 Recent developments & impact analysis, by key market participants
    • 4.1.1 Ansoff Matrix
  • 4.2 Major deals & strategic alliances analysis
    • 4.2.1 Joint Ventures
    • 4.2.2 Licensing and Partnerships
    • 4.2.3 Technological Collaborations
  • 4.3 Company/Competition Categorization
  • 4.4 Vendor Landscape
    • 4.4.1 List Of Key Distributors and Channel Partners
    • 4.4.2 Key Customers
  • 4.5 Public Companies
    • 4.5.1 Company Market Position Analysis
  • 4.6 Private Companies
    • 4.6.1 List Of Key Emerging Companies
    • 4.6.2 Regional Network Map

Chapter 5 Herpes Simplex Virus Treatment Market: Type Business Analysis

  • 5.1 Definition and Scope
  • 5.2 Type Market Share Analysis, 2023 & 2030
  • 5.3 Global Herpes Simplex Virus Treatment Market, By Type, 2018 To 2030
  • 5.4 Market Size & Forecasts and Trends Analysis, 2018 to 2030
    • 5.4.1 Herpes Simplex Virus-1 (HSV-1)
      • 5.4.1.1 Herpes Simplex Virus-1 (HSV-1) Market 2018 - 2030 (USD Million)
    • 5.4.2 Herpes Simplex Virus-2 (HSV-2)
      • 5.4.2.1 Herpes Simplex Virus-2 (HSV-2) Market, 2018 - 2030 (USD Million)

Chapter 6 Herpes Simplex Virus Treatment Market: Drug Business Analysis

  • 6.1 Definition and Scope
  • 6.2 Drug Market Share Analysis, 2023 & 2030
  • 6.3 Global Herpes Simplex Virus Treatment Market, By Drug, 2018 To 2030
  • 6.4 Market Size & Forecasts and Trends Analysis, 2018 to 2030
    • 6.4.1 Acyclovir
      • 6.4.1.1 Acyclovir Market 2018 - 2030 (USD Million)
    • 6.4.2 Valacyclovir
      • 6.4.2.1 Valacyclovir Market, 2018 - 2030 (USD Million)
    • 6.4.3 Famciclovir
      • 6.4.3.1 Famciclovir Market, 2018 - 2030 (USD Million)
    • 6.4.4 Other Drugs
      • 6.4.4.1 Other Drugs Market, 2018 - 2030 (USD Million)

Chapter 7 Herpes Simplex Virus Treatment Market: Vaccine Business Analysis

  • 7.1 Definition and Scope
  • 7.2 Vaccine Market Share Analysis, 2023 & 2030
  • 7.3 Global Herpes Simplex Virus Treatment Market, By Vaccine, 2018 To 2030
  • 7.4 Market Size & Forecasts and Trends Analysis, 2018 to 2030
    • 7.4.1 Simplirix
      • 7.4.1.1 Simplirix Market 2018 - 2030 (USD Million)
    • 7.4.2 Others
      • 7.4.2.1 Others Market, 2018 - 2030 (USD Million)

Chapter 8 Herpes Simplex Virus Treatment Market: Route of Administration Business Analysis

  • 8.1 Definition and Scope
  • 8.2 Route of Administration Market Share Analysis, 2023 & 2030
  • 8.3 Global Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 To 2030
  • 8.4 Market Size & Forecasts and Trends Analysis, 2018 to 2030
    • 8.4.1 Oral
      • 8.4.1.1 Oral Market 2018 - 2030 (USD Million)
    • 8.4.2 Injectable
      • 8.4.2.1 Injectable Market, 2018 - 2030 (USD Million)
    • 8.4.3 Topical
      • 8.4.3.1 Topical Market, 2018 - 2030 (USD Million)

Chapter 9 Herpes Simplex Virus Treatment Market: End-use Business Analysis

  • 9.1 Definition and Scope
  • 9.2 End-use Market Share Analysis, 2023 & 2030
  • 9.3 Global Herpes Simplex Virus Treatment Market, By End-use, 2018 To 2030
  • 9.4 Market Size & Forecasts and Trends Analysis, 2018 to 2030
    • 9.4.1 Hospital Pharmacy
      • 9.4.1.1 Hospital Pharmacy Market 2018 - 2030 (USD Million)
    • 9.4.2 Retail Pharmacy
      • 9.4.2.1 Retail Pharmacy Market, 2018 - 2030 (USD Million)
    • 9.4.3 Online Pharmacy
      • 9.4.3.1 Online Pharmacy Market, 2018 - 2030 (USD Million)

Chapter 10 Herpes Simplex Virus Treatment Market: Regional Business Analysis

  • 10.1 Definition & Scope
  • 10.2 Regional Market Share Analysis, 2023 & 2030
  • 10.3 Regional Market Dashboard
  • 10.4 Regional Market Snapshot
  • 10.5 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
    • 10.5.1 North America
    • 10.5.2 Europe
    • 10.5.3 Asia Pacific
    • 10.5.4 Latin America
    • 10.5.5 MEA
  • 10.6 Market Size, & Forecasts, Trends Analysis, 2023 to 2030
  • 10.7 North America
    • 10.7.1 North America Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
    • 10.7.2 U.S.
      • 10.7.2.1 U.S. Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
    • 10.7.3 Canada
      • 10.7.3.1 Canada Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
  • 10.8 Europe
    • 10.8.1 Europe Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
    • 10.8.2 UK
      • 10.8.2.1 UK Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
    • 10.8.3 Germany
      • 10.8.3.1 Germany Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
    • 10.8.4 France
      • 10.8.4.1 France Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
    • 10.8.5 Italy
      • 10.8.5.1 Italy Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
    • 10.8.6 Spain
      • 10.8.6.1 Spain Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
    • 10.8.7 Denmark
      • 10.8.7.1 Denmark Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
    • 10.8.8 Sweden
      • 10.8.8.1 Sweden Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
    • 10.8.9 Norway
      • 10.8.9.1 Norway Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
  • 10.9 Asia Pacific
    • 10.9.1 Asia-Pacific Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
    • 10.9.2 Japan
      • 10.9.2.1 Japan Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
    • 10.9.3 China
      • 10.9.3.1 China Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
    • 10.9.4 India
      • 10.9.4.1 India Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
    • 10.9.5 Australia
      • 10.9.5.1 Australia Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
    • 10.9.6 South Korea
      • 10.9.6.1 South Korea Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
    • 10.9.7 Thailand
      • 10.9.7.1 Thailand Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
  • 10.10 Latin America
    • 10.10.1 Latin America Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
    • 10.10.2 Brazil
      • 10.10.2.1 Brazil Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
    • 10.10.3 Mexico
      • 10.10.3.1 Mexico Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
    • 10.10.4 Argentina
      • 10.10.4.1 Argentina Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
  • 10.11 MEA
    • 10.11.1 MEA Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
    • 10.11.2 South Africa
      • 10.11.2.1 South Africa Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
    • 10.11.3 Saudi Arabia
      • 10.11.3.1 Saudi Arabia Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
    • 10.11.4 UAE
      • 10.11.4.1 UAE Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
    • 10.11.5 Kuwait
      • 10.11.5.1 Kuwait Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)

Chapter 11 Herpes Simplex Virus Treatment Market: Company Profiling

  • 11.1 Company Profiles
    • 11.1.1. GSK plc
      • 11.1.1.1 Company Overview
      • 11.1.1.2 Financial Performance
      • 11.1.1.3 Product Benchmarking
      • 11.1.1.4 Strategic Initiatives
    • 11.1.2. Carlsbad Tech
      • 11.1.2.1 Company Overview
      • 11.1.2.2 Financial Performance
      • 11.1.2.3 Product Benchmarking
      • 11.1.2.4 Strategic Initiatives
    • 11.1.3. Emcure Pharmaceuticals Ltd.,
      • 11.1.3.1 Company Overview
      • 11.1.3.2 Financial Performance
      • 11.1.3.3 Product Benchmarking
      • 11.1.3.4 Strategic Initiatives
    • 11.1.4. Sanofi
      • 11.1.4.1 Company Overview
      • 11.1.4.2 Financial Performance
      • 11.1.4.3 Product Benchmarking
      • 11.1.4.4 Strategic Initiatives
    • 11.1.5. Glenmark Pharmaceuticals Inc.
      • 11.1.5.1 Company Overview
      • 11.1.5.2 Financial Performance
      • 11.1.5.3 Product Benchmarking
      • 11.1.5.4 Strategic Initiatives
    • 11.1.6. Fresenius Kabi AG
      • 11.1.6.1 Company Overview
      • 11.1.6.2 Financial Performance
      • 11.1.6.3 Product Benchmarking
      • 11.1.6.4 Strategic Initiatives
    • 11.1.7. Apotex Inc.
      • 11.1.7.1 Company Overview
      • 11.1.7.2 Financial Performance
      • 11.1.7.3 Product Benchmarking
      • 11.1.7.4 Strategic Initiatives
    • 11.1.8. Viatris Inc. (Mylan)
      • 11.1.8.1 Company Overview
      • 11.1.8.2 Financial Performance
      • 11.1.8.3 Product Benchmarking
      • 11.1.8.4 Strategic Initiatives
    • 11.1.9 Teva Pharmaceuticals Industries Ltd.
      • 11.1.11.1 Company Overview
      • 11.1.9.2 Financial Performance
      • 11.1.9.3 Product Benchmarking
      • 11.1.9.4 Strategic Initiatives

List of Tables

  • TABLE 1 List of Secondary Sources
  • TABLE 2 List of Abbreviations
  • TABLE 3 Regulatory Framework
  • TABLE 4 Global Herpes Simplex Virus Treatment Market, By Region, 2018 - 2030 (USD Million)
  • TABLE 5 Global Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 6 Global Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • TABLE 7 Global Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
  • TABLE 8 Global Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • TABLE 9 Global Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 10 North America Herpes Simplex Virus Treatment Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 11 North America Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 12 North America Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • TABLE 13 North America Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
  • TABLE 14 North America Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • TABLE 15 North America Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 16 U.S. Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 17 U.S. Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • TABLE 18 U.S. Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
  • TABLE 19 U.S. Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • TABLE 20 U.S. Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 21 Canada Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 22 Canada Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • TABLE 23 Canada Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
  • TABLE 24 Canada Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • TABLE 25 Canada Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 26 Europe Herpes Simplex Virus Treatment Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 27 Europe Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 28 Europe Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • TABLE 29 Europe Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
  • TABLE 30 Europe Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • TABLE 31 Europe Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 32 UK Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 33 UK Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • TABLE 34 UK Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
  • TABLE 35 UK Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • TABLE 36 UK Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 37 Germany Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 38 Germany Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • TABLE 39 Germany Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
  • TABLE 40 Germany Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • TABLE 41 Germany Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 42 France Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 43 France Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • TABLE 44 France Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
  • TABLE 45 France Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • TABLE 46 France Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 47 Spain Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 48 Spain Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • TABLE 49 Spain Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
  • TABLE 50 Spain Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • TABLE 51 Spain Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 52 Italy Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 53 Italy Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • TABLE 54 Italy Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
  • TABLE 55 Italy Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • TABLE 56 Italy Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 57 Denmark Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 58 Denmark Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • TABLE 59 Denmark Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
  • TABLE 60 Denmark Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • TABLE 61 Denmark Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 62 Sweden Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 63 Sweden Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • TABLE 64 Sweden Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
  • TABLE 65 Sweden Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • TABLE 66 Sweden Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 67 Norway Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 68 Norway Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • TABLE 69 Norway Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
  • TABLE 70 Norway Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • TABLE 71 Norway Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 72 Asia Pacific Herpes Simplex Virus Treatment Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 73 Asia Pacific Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 74 Asia Pacific Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • TABLE 75 Asia Pacific Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
  • TABLE 76 Asia Pacific Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • TABLE 77 Asia Pacific Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 78 China Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 79 China Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • TABLE 80 China Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
  • TABLE 81 China Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • TABLE 82 China Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 83 Japan Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 84 Japan Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • TABLE 85 Japan Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
  • TABLE 86 Japan Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • TABLE 87 Japan Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 88 India Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 89 India Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • TABLE 90 India Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
  • TABLE 91 India Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • TABLE 92 India Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 93 South Korea Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 94 South Korea Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • TABLE 95 South Korea Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
  • TABLE 96 South Korea Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • TABLE 97 South Korea Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 98 Australia Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 99 Australia Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • TABLE 100 Australia Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
  • TABLE 101 Australia Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • TABLE 102 Australia Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 103 Thailand Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 104 Thailand Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • TABLE 105 Thailand Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
  • TABLE 106 Thailand Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • TABLE 107 Thailand Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 108 Latin America Herpes Simplex Virus Treatment Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 109 Latin America Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 110 Latin America Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • TABLE 111 Latin America Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
  • TABLE 112 Latin America Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • TABLE 113 Latin America Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 114 Brazil Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 115 Brazil Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • TABLE 116 Brazil Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
  • TABLE 117 Brazil Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • TABLE 118 Brazil Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 119 Mexico Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 120 Mexico Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • TABLE 121 Mexico Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
  • TABLE 122 Mexico Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • TABLE 123 Mexico Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 124 Argentina Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 125 Argentina Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • TABLE 126 Argentina Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
  • TABLE 127 Argentina Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • TABLE 128 Argentina Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 129 MEA Herpes Simplex Virus Treatment Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 130 MEA Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 131 MEA Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • TABLE 132 MEA Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
  • TABLE 133 MEA Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • TABLE 134 MEA Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 135 South Africa Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 136 South Africa Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • TABLE 137 South Africa Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
  • TABLE 138 South Africa Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • TABLE 139 South Africa Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 140 Saudi Arabia Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 141 Saudi Arabia Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • TABLE 142 Saudi Arabia Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
  • TABLE 143 Saudi Arabia Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • TABLE 144 Saudi Arabia Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 145 UAE Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 146 UAE Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • TABLE 147 UAE Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
  • TABLE 148 UAE Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • TABLE 149 UAE Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 150 Kuwait Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 151 Kuwait Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • TABLE 152 Kuwait Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
  • TABLE 153 Kuwait Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • TABLE 154 Kuwait Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market Research Process
  • FIG. 2 Information Procurement
  • FIG. 3 Primary Research Pattern
  • FIG. 4 Market Research Approaches
  • FIG. 5 Value Chain-Based Sizing & Forecasting
  • FIG. 6 Market Formulation & Validation
  • FIG. 7 Herpes Simplex Virus Treatment Market Segmentation
  • FIG. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • FIG. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • FIG. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • FIG. 11 Penetration & Growth Prospect Mapping
  • FIG. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • FIG. 13 Porter's Five Forces Analysis
  • FIG. 14 Market Penetration & Growth Prospect Mapping
  • FIG. 15 Herpes Simplex Virus Treatment Market: Treatment Movement Analysis
  • FIG. 16 Herpes Simplex Virus-1 (HSV-1)market, 2018 - 2030 (USD Million)
  • FIG. 17 Herpes simplex virus-2 (HSV-2)market, 2018 - 2030 (USD Million)
  • FIG. 18 Herpes Simplex Virus Treatment Market: Drug Movement Analysis
  • FIG. 19 Acyclovir market, 2018 - 2030 (USD Million)
  • FIG. 20 Valacyclovir market, 2018 - 2030 (USD Million)
  • FIG. 21 Famciclovir market, 2018 - 2030 (USD Million)
  • FIG. 22 Others drugs market, 2018 - 2030 (USD Million)
  • FIG. 23 Herpes Simplex Virus Treatment Market: Vaccine Movement Analysis
  • FIG. 24 Herpes Simplex Virus Treatment Market: Route of Administration Movement Analysis
  • FIG. 25 Oral market, 2018 - 2030 (USD Million)
  • FIG. 26 Injectable market, 2018 - 2030 (USD Million)
  • FIG. 27 Topical market, 2018 - 2030 (USD Million)
  • FIG. 28 Herpes Simplex Virus Treatment Market: End-use Movement Analysis
  • FIG. 29 Hospital pharmacy market, 2018 - 2030 (USD Million)
  • FIG. 30 Retail pharmacy market, 2018 - 2030 (USD Million)
  • FIG. 31 Online pharmacy market, 2018 - 2030 (USD Million)
  • FIG. 32 Regional Marketplace: Key Takeaways
  • FIG. 33 Regional Outlook, 2018 & 2030
  • FIG. 34 Regional Market Dashboard
  • FIG. 35 Regional Market Place: Key Takeaways
  • FIG. 36 North America, SWOT Analysis
  • FIG. 37 Europe, SWOT Analysis
  • FIG. 38 Asia Pacific, SWOT Analysis
  • FIG. 39 Latin America, SWOT Analysis
  • FIG. 40 MEA, SWOT Analysis
  • FIG. 41 North America
  • FIG. 42 North America Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • FIG. 43 U.S. Key Country Dynamics
  • FIG. 44 U.S. Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • FIG. 45 Canada Key Country Dynamics
  • FIG. 46 Canada Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • FIG. 47 Europe
  • FIG. 48 Europe Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • FIG. 49 UK Key Country Dynamics
  • FIG. 50 UK Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • FIG. 51 Germany Key Country Dynamics
  • FIG. 52 Germany Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • FIG. 53 France Key Country Dynamics
  • FIG. 54 France Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • FIG. 55 Italy Key Country Dynamics
  • FIG. 56 Italy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • FIG. 57 Spain Key Country Dynamics
  • FIG. 58 Spain Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • FIG. 59 Denmark Key Country Dynamics
  • FIG. 60 Denmark Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • FIG. 61 Sweden Key Country Dynamics
  • FIG. 62 Sweden Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • FIG. 63 Norway Key Country Dynamics
  • FIG. 64 Norway Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • FIG. 65 Asia Pacific
  • FIG. 66 Asia-Pacific Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • FIG. 67 Japan Key Country Dynamics
  • FIG. 68 Japan Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • FIG. 69 China Key Country Dynamics
  • FIG. 70 China Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • FIG. 71 India Key Country Dynamics
  • FIG. 72 India Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • FIG. 73 Australia Key Country Dynamics
  • FIG. 74 Australia Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • FIG. 75 South Korea Key Country Dynamics
  • FIG. 76 South Korea Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • FIG. 77 Thailand Key Country Dynamics
  • FIG. 78 Thailand Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • FIG. 79 Latin America
  • FIG. 80 Latin America Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • FIG. 81 Brazil Key Country Dynamics
  • FIG. 82 Brazil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • FIG. 83 Mexico Key Country Dynamics
  • FIG. 84 Mexico Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • FIG. 85 Argentina Key Country Dynamics
  • FIG. 86 Argentina Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • FIG. 87 MEA
  • FIG. 88 MEA Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • FIG. 89 South Africa Key Country Dynamics
  • FIG. 90 South Africa Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • FIG. 91 Saudi Arabia Key Country Dynamics
  • FIG. 92 Saudi Arabia Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • FIG. 93 UAE Key Country Dynamics
  • FIG. 94 UAE Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • FIG. 95 Kuwait Key Country Dynamics
  • FIG. 96 Kuwait Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • FIG. 97 Strategy Mapping